Trial Profile

Onyx ONE Study; A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 20 Apr 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Umirolimus (Primary) ; Zotarolimus (Primary)
Indications Coronary artery disease
Focus Therapeutic Use
Acronyms Onyx ONE

Most Recent Events

17 May 2021 Results presented at the 70th Annual Scientific Session of the American College of Cardiology
01 Dec 2020 Status changed from active, no longer recruiting to completed.
05 Jun 2020 According to an Medtronic media release, the indication is based on results from this Onyx ONE Global Study.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com